Literature DB >> 31659457

Fragility fractures and imminent fracture risk in Hong Kong: one of the cities with longest life expectancies.

Ronald Man Yeung Wong1, Wing Tung Ho1, Law Sheung Wai1, Wilson Li2, Wai Wang Chau1, Kwoon-Ho Simon Chow1, Wing-Hoi Cheung3.   

Abstract

INTRODUCTION: Imminent fracture risk, or fractures within 2 years of an initial fracture, is a pressing issue worldwide. Hong Kong is a city with one of the longest life expectancies. The concern of fragility fractures and the imminent risk of a subsequent fracture is becoming a top priority. The objective of this study was to present the epidemiology of incident fragility fractures of all public acute hospitals and the imminent risk of a subsequent fracture in Hong Kong.
METHODOLOGY: This was a retrospective population-based analysis. Patient records from all acute hospitals in Hong Kong from 1 January 2004 to 31 December 2018 were retrieved for patients ≥ 50 years of age with hip, distal radius, or proximal humerus fractures. Secondary fractures and falls were identified in the subsequent 5 years. Post hoc analysis in recent 2013-2018 period was performed. Overall survival (re-fracture incidence) on age subgroups using Kaplan survival analysis and variables was compared using the log-rank test. Cox proportional hazard regressions, obtaining the hazard ratios (HR) and their respective 95% confidence intervals (CI), were used.
RESULTS: There is an overall increasing trend of fragility fractures (hip, distal radius, proximal humerus) from 5596 in 2004 to 8465 in 2018. The average cumulative imminent risk of fractures from recent 5 years is 3.87% at 1 year and 6.50% at 2 years. 49.5% of the patients with a secondary fracture occurred within 2 years since the initial major fragility fracture. Post hoc analysis in recent 2013-2018 period (N = 7039) showed male patients were 1.21 times more likely to have further fractures with time (HR = 1.21 (1.02, 1.45), p = 0.03) compared with female patients. Patients over age 95 were 2.01 times higher than patients of age under 75 to have further fracture over time.
CONCLUSIONS: Following an initial fracture, prompt treatment strategies should be adopted to avoid imminent risk of fractures. This window of opportunity in the first 2 years is a golden period to treat osteoporosis and prevent falls. Our post hoc analysis has shown that male patients and patients older than 95 are at even higher risk. Clinicians and allied healthcare professionals should be alert on these patients.

Entities:  

Keywords:  Fragility fractures; Imminent fracture risk; Osteoporosis; Osteoporotic fracture; Sarcopenia

Mesh:

Year:  2019        PMID: 31659457     DOI: 10.1007/s11657-019-0648-4

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  11 in total

1.  The first reported fracture liaison service (FLS) for vertebral fractures in China: is muscle the missing gap?

Authors:  Ronald Man Yeung Wong; Shaau Yiu Ko; Wai-Wang Chau; Linus Chee Yeen Lee; Simon Kwoon Ho Chow; Wing Hoi Cheung; Sheung Wai Law
Journal:  Arch Osteoporos       Date:  2021-11-06       Impact factor: 2.617

2.  Montreal cognitive assessment (MoCA) is highly correlated with 1-year mortality in hip fracture patients.

Authors:  R M Y Wong; R W K Ng; W W Chau; W H Liu; S K H Chow; C Y Tso; N Tang; W-H Cheung
Journal:  Osteoporos Int       Date:  2022-06-28       Impact factor: 5.071

3.  Risk factors of refracture after a fragility fracture in elderly.

Authors:  Kaiwan Sriruanthong; Nattaphon Philawuth; Surapot Saloa; Nuttorn Daraphongsataporn; Worapong Sucharitpongpan
Journal:  Arch Osteoporos       Date:  2022-07-25       Impact factor: 2.879

4.  Recommendations on the post-acute management of the osteoporotic fracture - Patients with "very-high" Re-fracture risk.

Authors:  Ronald Man Yeung Wong; Wing-Hoi Cheung; Simon Kwoon Ho Chow; Raymond Wai Kit Ng; Wilson Li; Albert Yung-Chak Hsu; Kam Kwong Wong; Angela Wing-Hang Ho; Shing-Hing Choi; Christian Xinshuo Fang; Chun Fung Chan; Ka-Hei Leung; Kwok-Keung Chu; Timothy Chi Yui Kwok; Ming Hui Yang; Maoyi Tian; Sheung Wai Law
Journal:  J Orthop Translat       Date:  2022-10-10       Impact factor: 4.889

Review 5.  The effectiveness of exercises on fall and fracture prevention amongst community elderlies: A systematic review and meta-analysis.

Authors:  R M Y Wong; K C Chong; S W Law; W T Ho; J Li; C S Chui; S K H Chow; W H Cheung
Journal:  J Orthop Translat       Date:  2020-06-01       Impact factor: 5.191

6.  Short time horizons for fracture prediction tools: time for a rethink.

Authors:  E V McCloskey; F Borgstrom; C Cooper; N C Harvey; M K Javaid; M Lorentzon; J A Kanis
Journal:  Osteoporos Int       Date:  2021-04-29       Impact factor: 4.507

7.  3D printing in orthopaedic surgery: a scoping review of randomized controlled trials.

Authors:  Ronald Man Yeung Wong; Pui Yan Wong; Chaoran Liu; Yik Lok Chung; Kwok Chuen Wong; Chi Yin Tso; Simon Kwoon-Ho Chow; Wing-Hoi Cheung; Patrick Shu-Hang Yung; Chun Sing Chui; Sheung Wai Law
Journal:  Bone Joint Res       Date:  2021-12       Impact factor: 5.853

8.  High Charlson Comorbidity Index Score is associated with early fracture-related complication for internal fixation of neck of femur fractures.

Authors:  Ronald Man Yeung Wong; Yao Zu; Wai Wang Chau; Chi Yin Tso; Wing Hong Liu; Raymond Wai Kit Ng; Simon Kwoon Ho Chow; Wing Hoi Cheung; Ning Tang; Kevin Ki Wai Ho
Journal:  Sci Rep       Date:  2022-03-19       Impact factor: 4.379

9.  Fracture-related infection in osteoporotic bone causes more severe infection and further delays healing.

Authors:  Jie Li; Ronald Man Yeung Wong; Yik Lok Chung; Sharon Shui Yee Leung; Simon Kwoon-Ho Chow; Margaret Ip; Wing-Hoi Cheung
Journal:  Bone Joint Res       Date:  2022-02       Impact factor: 5.853

10.  Prognostic factors related to ambulation deterioration after 1-year of geriatric hip fracture in a Chinese population.

Authors:  Ronald Man Yeung Wong; Jianghui Qin; Wai Wang Chau; Ning Tang; Chi Yin Tso; Hiu Wun Wong; Simon Kwoon-Ho Chow; Kwok-Sui Leung; Wing-Hoi Cheung
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.